Stock comparison
Mettler-Toledo International
Viking Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
VKTX
Viking Therapeutics
Market cap
$3.59B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | VKTX | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 18F | MTD |
| Benjamin Graham | 65B | 53D | MTD |
| Philip Fisher | 63C | 36D | MTD |
| Peter Lynch | 66B | 10F | MTD |
| Joel Greenblatt | 68B | 0F | MTD |
| Charlie Munger | 74B | 24F | MTD |
| Terry Smith | 70B | 28F | MTD |
Side-by-side metrics
| Metric | MTD | VKTX |
|---|---|---|
| Market cap | $22.29B | $3.59B |
| P/E (TTM) | 25.3x | - |
| EV/EBIT | 21.6x | - |
| ROIC (TTM) | 36.09% | -100.02% |
| Gross margin | 57.79% | 0.0% |
| Net margin | 21.4% | 0.0% |
| Revenue CAGR 5y | 2.01% | - |
| EPS CAGR 5y | 6.12% | - |
| Debt / Equity | - | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- ROIC (TTM)36.09%vs -100.02%+136%
- Gross margin57.79%vs 0.0%+100%
- Net margin21.4%vs 0.0%+100%
- Debt / Equity-vs -+100%
VKTX leads on
- EV/EBIT-vs 21.6x+138%
- P/E (TTM)-vs 25.3x+128%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.